Table of Contents Author Guidelines Submit a Manuscript
Stem Cells International
Volume 2014, Article ID 197154, 11 pages
http://dx.doi.org/10.1155/2014/197154
Research Article

Magnetic Nanoparticle Based Nonviral MicroRNA Delivery into Freshly Isolated CD105+ hMSCs

Department of Cardiac Surgery, Reference and Translation Center for Cardiac Stem Cell Therapy (RTC), University of Rostock, Schillingallee 35, 18057 Rostock, Germany

Received 31 January 2014; Accepted 2 March 2014; Published 31 March 2014

Academic Editor: Katherine Athayde Teixeira de Carvalho

Copyright © 2014 Anna Schade et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. Dominici, K. le Blanc, I. Mueller et al., “Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement,” Cytotherapy, vol. 8, no. 4, pp. 315–317, 2006. View at Publisher · View at Google Scholar · View at Scopus
  2. H. Aslan, Y. Zilberman, L. Kandel et al., “Osteogenic differentiation of noncultured immunoisolated bone marrow-derived CD105+ cells,” Stem Cells, vol. 24, no. 7, pp. 1728–1737, 2006. View at Publisher · View at Google Scholar · View at Scopus
  3. A. I. Caplan, “Adult mesenchymal stem cells for tissue engineering versus regenerative medicine,” Journal of Cellular Physiology, vol. 213, no. 2, pp. 341–347, 2007. View at Publisher · View at Google Scholar · View at Scopus
  4. Z. Wen, S. Zheng, C. Zhou, W. Yuan, J. Wang, and T. Wang, “Bone marrow mesenchymal stem cells for post-myocardial infarction cardiac repair: microRNAs as novel regulators,” Journal of Cellular and Molecular Medicine, vol. 16, no. 4, pp. 657–671, 2012. View at Publisher · View at Google Scholar
  5. J. J. Chen and S. H. Zhou, “Mesenchymal stem cells overexpressing MiR-126 enhance ischemic angiogenesis via the AKT/ERK-related pathway,” Cardiology Journal, vol. 18, no. 6, pp. 675–681, 2011. View at Google Scholar · View at Scopus
  6. F. Huang, X. Zhu, X. Q. Hu et al., “Mesenchymal stem cells modified with miR-126 release angiogenic factors and activate Notch ligand Delta-like-4, enhancing ischemic angiogenesis and cell survival,” International Journal of Molecular Medicine, vol. 31, no. 2, pp. 484–492, 2013. View at Publisher · View at Google Scholar
  7. M. Tome, P. Lopez-Romero, C. Albo et al., “miR-335 orchestrates cell proliferation, migration and differentiation in human mesenchymal stem cells,” Cell Death and Differentiation, vol. 18, no. 6, pp. 985–995, 2011. View at Publisher · View at Google Scholar · View at Scopus
  8. P. Jakob and U. Landmesser, “Role of microRNAs in stem/progenitor cells and cardiovascular repair,” Cardiovascular Research, vol. 93, no. 4, pp. 614–622, 2012. View at Publisher · View at Google Scholar · View at Scopus
  9. H. Boulaiz, J. A. Marchal, J. Prados, C. Melguizo, and A. Aranega, “Non-viral and viral vectors for gene therapy,” Cellular and Molecular Biology, vol. 51, no. 1, pp. 3–22, 2005. View at Google Scholar · View at Scopus
  10. F. H. Lin, C. H. Chen, W. T. Cheng, and T. F. Kuo, “Modified montmorillonite as vector for gene delivery,” Biomaterials, vol. 27, no. 17, pp. 3333–3338, 2006. View at Publisher · View at Google Scholar · View at Scopus
  11. T. Bieber, W. Meissner, S. Kostin, A. Niemann, and H. P. Elsasser, “Intracellular route and transcriptional competence of polyethylenimine-DNA complexes,” Journal of Controlled Release, vol. 82, no. 2-3, pp. 441–454, 2002. View at Publisher · View at Google Scholar · View at Scopus
  12. M. A. Mintzer and E. E. Simanek, “Nonviral vectors for gene delivery,” Chemical Reviews, vol. 109, no. 2, pp. 259–302, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. S. Zhang, B. Zhao, H. Jiang, B. Wang, and B. Ma, “Cationic lipids and polymers mediated vectors for delivery of siRNA,” Journal of Controlled Release, vol. 123, no. 1, pp. 1–10, 2007. View at Publisher · View at Google Scholar · View at Scopus
  14. E. Delyagina, W. Li, N. Ma, and G. Steinhoff, “Magnetic targeting strategies in gene delivery,” Nanomedicine, vol. 6, no. 9, pp. 1593–1604, 2011. View at Publisher · View at Google Scholar · View at Scopus
  15. F. Scherer, M. Anton, U. Schillinger et al., “Magnetofection: enhancing and targeting gene delivery by magnetic force in vitro and in vivo,” Gene Therapy, vol. 9, no. 2, pp. 102–109, 2002. View at Publisher · View at Google Scholar · View at Scopus
  16. H. H. Yiu, S. C. McBain, Z. A. Lethbridge, M. R. Lees, and J. Dobson, “Preparation and characterization of polyethylenimine-coated Fe3O4-MCM-48 nanocomposite particles as a novel agent for magnet-assisted transfection,” Journal of Biomedical Materials Research A, vol. 92, no. 1, pp. 386–392, 2010. View at Publisher · View at Google Scholar · View at Scopus
  17. P. del Pino, A. Munoz-Javier, D. Vlaskou, P. Rivera Gil, C. Plank, and W. J. Parak, “Gene silencing mediated by magnetic lipospheres tagged with small interfering RNA,” Nano Letters, vol. 10, no. 10, pp. 3914–3921, 2010. View at Publisher · View at Google Scholar · View at Scopus
  18. J. Lim, M. A. Clements, and J. Dobson, “Delivery of short interfering ribonucleic acid-complexed magnetic nanoparticles in an oscillating field occurs via caveolae-mediated endocytosis,” PLoS ONE, vol. 7, no. 12, article e51350, 2012. View at Publisher · View at Google Scholar
  19. C. Plank, O. Zelphati, and O. Mykhaylyk, “Magnetically enhanced nucleic acid delivery. Ten years of magnetofection-Progress and prospects,” Advanced Drug Delivery Reviews, vol. 63, no. 14-15, pp. 1300–1331, 2011. View at Publisher · View at Google Scholar · View at Scopus
  20. W. Li, N. Ma, L.-L. Ong et al., “Enhanced thoracic gene delivery by magnetic nanobead-mediated vector,” The Journal of Gene Medicine, vol. 10, no. 8, pp. 897–909, 2008. View at Publisher · View at Google Scholar · View at Scopus
  21. E. Delyagina, A. Schade, D. Scharfenberg et al., “Improved transfection in human mesenchymal stem cells: effective intracellular release of pDNA by magnetic polyplexes,” Nanomedicine, 2013. View at Publisher · View at Google Scholar
  22. A. Schade, E. Delyagina, D. Scharfenberg et al., “Innovative strategy for microRNA delivery in human mesenchymal stem cells via magnetic nanoparticles,” International Journal of Molecular Sciences, vol. 14, no. 6, pp. 10710–10726, 2013. View at Publisher · View at Google Scholar
  23. S. Bobis, D. Jarocha, and M. Majka, “Mesenchymal stem cells: characteristics and clinical applications,” Folia Histochemica et Cytobiologica, vol. 44, no. 4, pp. 215–230, 2006. View at Google Scholar · View at Scopus
  24. P. Mark, M. Kleinsorge, R. Gaebel et al., “Human mesenchymal stem cells display reduced expression of CD105 after culture in serum-free medium,” Stem Cells International, vol. 2013, Article ID 698076, 8 pages, 2013. View at Publisher · View at Google Scholar
  25. http://clinicaltrials.gov/.
  26. W. J. Rombouts and R. E. Ploemacher, “Primary murine MSC show highly efficient homing to the bone marrow but lose homing ability following culture,” Leukemia, vol. 17, no. 1, pp. 160–170, 2003. View at Publisher · View at Google Scholar · View at Scopus
  27. R. Gaebel, D. Furlani, H. Sorg et al., “Cell origin of human mesenchymal stem cells determines a different healing performance in cardiac regeneration,” PLoS ONE, vol. 6, no. 2, e15652, 2011. View at Publisher · View at Google Scholar · View at Scopus
  28. W. Wang, W. Li, L. Ou et al., “Polyethylenimine-mediated gene delivery into human bone marrow mesenchymal stem cells from patients,” Journal of Cellular and Molecular Medicine, vol. 15, no. 9, pp. 1989–1998, 2011. View at Publisher · View at Google Scholar · View at Scopus
  29. Y. H. Choi, A. Kurtz, and C. Stamm, “Mesenchymal stem cells for cardiac cell therapy,” Human Gene Therapy, vol. 22, no. 1, pp. 3–17, 2011. View at Publisher · View at Google Scholar · View at Scopus
  30. M. F. Pittenger and B. J. Martin, “Mesenchymal stem cells and their potential as cardiac therapeutics,” Circulation Research, vol. 95, no. 1, pp. 9–20, 2004. View at Publisher · View at Google Scholar · View at Scopus
  31. A. Judge and I. MacLachlan, “Overcoming the innate immune response to small interfering RNA,” Human Gene Therapy, vol. 19, no. 2, pp. 111–124, 2008. View at Publisher · View at Google Scholar · View at Scopus
  32. W. T. Godbey, K. K. Wu, and A. G. Mikos, “Poly(ethylenimine) and its role in gene delivery,” Journal of Controlled Release, vol. 60, no. 2-3, pp. 149–160, 1999. View at Publisher · View at Google Scholar · View at Scopus
  33. S. Huth, J. Lausier, S. W. Gersting et al., “Insights into the mechanism of magnetofection using PEI-based magnetofectins for gene transfer,” The Journal of Gene Medicine, vol. 6, no. 8, pp. 923–936, 2004. View at Publisher · View at Google Scholar · View at Scopus
  34. http://www.ozbiosciences.com/.
  35. S. N. Uddin, “Cationic lipids used in non-viral gene delivery systems,” Biotechnology and Molecular Biology Review, vol. 2, pp. 58–67, 2007. View at Google Scholar
  36. Y. Zhang, W. Li, L. Ou et al., “Targeted delivery of human VEGF gene via complexes of magnetic nanoparticle-adenoviral vectors enhanced cardiac regeneration,” PLoS ONE, vol. 7, no. 7, article e39490. View at Publisher · View at Google Scholar